Literature DB >> 9039491

Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis.

S Lindberg1, A Cervin, T Runer.   

Abstract

The nasal concentration of nitric oxide (NO) was measured by chemiluminescence in healthy volunteers 3-68 years of age, and in patients suffering from common cold and chronic sinusitis. The concentration of NO in healthy subjects, 233.2 +/- 66.8 ppb (mean +/- SD), was found to be relatively independent of age and body size. The measured levels of NO did not differ between healthy volunteers and common cold patients, but they were significantly lower in patients suffering from chronic sinusitis, 96.4 +/- 72.8 ppb. As NO is a regulator of mucociliary activity and has bacteriostatic and antiviral effects, the decreased concentration of NO in patients suffering from sinusitis suggests that lack of NO may contribute to the pathogenesis of this disease. The importance of NO for the mucociliary system was emphasized by the finding that the 2 patients with the lowest nasal concentration of NO were found to manifest functional and morphological changes of the mucociliary system that are typical of acquired mucociliary dysfunction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039491     DOI: 10.3109/00016489709118001

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  14 in total

Review 1.  Nasal nitric oxide in man.

Authors:  J O Lundberg; E Weitzberg
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

Review 2.  Primary ciliary dyskinesia, an orphan disease.

Authors:  Mieke Boon; Mark Jorissen; Marijke Proesmans; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

Review 3.  Chronic Rhinosinusitis without Nasal Polyps.

Authors:  Seong Ho Cho; Dae Woo Kim; Philippe Gevaert
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Jul-Aug

4.  Nasal NO measurement by direct sampling from the nose during breathhold: Aspiration flow, nasal resistance and reproducibility.

Authors:  V M D Struben; M H Wieringa; C J Mantingh; J C de Jongste; L Feenstra
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-19       Impact factor: 2.503

5.  Correlation of nasal nitric oxide measurement with computed tomography findings in chronic rhinosinusitis.

Authors:  Yogesh G Dabholkar; Akanksha A Saberwal; Haritosh K Velankar; Adip K Shetty; Nilesh P Chordia; Sneha R Budhwani
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-11-20

Review 6.  Advances in the Genetics of Primary Ciliary Dyskinesia: Clinical Implications.

Authors:  Amjad Horani; Thomas W Ferkol
Journal:  Chest       Date:  2018-05-22       Impact factor: 9.410

Review 7.  Primary Ciliary Dyskinesia: An Update on New Diagnostic Modalities and Review of the Literature.

Authors:  Rizwana Popatia; Kenan Haver; Alicia Casey
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-06-01       Impact factor: 1.349

8.  Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia.

Authors:  I Horváth; S Loukides; T Wodehouse; E Csiszér; P J Cole; S A Kharitonov; P J Barnes
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

Review 9.  [Function and physiology of the maxillary sinus].

Authors:  H L Sieron; F Sommer; T K Hoffmann; A-S Grossi; M O Scheithauer; F Stupp; J Lindemann
Journal:  HNO       Date:  2020-08       Impact factor: 1.284

10.  Liposome-encapsulated ISMN: a novel nitric oxide-based therapeutic agent against Staphylococcus aureus biofilms.

Authors:  Camille Jardeleza; Shasha Rao; Benjamin Thierry; Pratik Gajjar; Sarah Vreugde; Clive A Prestidge; Peter-John Wormald
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.